普蕊斯(301257) - 2024 Q3 - 季度财报

Key Financial Data In the first three quarters of 2024, the company's operating revenue achieved stable growth, but net profit attributable to shareholders and non-recurring net profit both significantly declined, with operating cash flow turning negative primarily due to increased personnel costs, reduced collections, and decreased government subsidies Key Accounting Data and Financial Indicators For the period from the beginning of the year to the end of the reporting period (January-September), the company's operating revenue was 594 million yuan, a 9.17% year-on-year increase, while net profit attributable to shareholders significantly decreased by 28.39% to 72.26 million yuan, and basic earnings per share declined by 35.12% Key Accounting Data and Financial Indicators | Indicator | Year-to-Date (Jan-Sep) | Year-on-Year Change (%) | | :--- | :--- | :--- | | Operating Revenue (Yuan) | 593,655,432.66 | 9.17% | | Net Profit Attributable to Shareholders of Listed Company (Yuan) | 72,264,346.75 | -28.39% | | Net Profit Attributable to Shareholders of Listed Company Excluding Non-recurring Gains and Losses (Yuan) | 62,498,715.42 | -27.42% | | Net Cash Flow from Operating Activities (Yuan) | -25,890,406.88 | -130.03% | | Basic Earnings Per Share (Yuan/Share) | 1.09 | -35.12% | | Weighted Average Return on Net Assets | 6.47% | -3.64% | | Indicator | As of End of Current Period | Change from End of Prior Year (%) | | Total Assets (Yuan) | 1,380,627,358.88 | 1.01% | | Owners' Equity Attributable to Shareholders of Listed Company (Yuan) | 1,140,769,067.05 | 5.57% | Non-recurring Gains and Losses Items From the beginning of the year to the end of the reporting period, total non-recurring gains and losses amounted to 9.77 million yuan, primarily from 11.23 million yuan in gains from the disposal and holding of financial assets held for trading Non-recurring Gains and Losses Items | Item | Year-to-Date Amount (Yuan) | Explanation | | :--- | :--- | :--- | | Gains and Losses from Disposal of Non-current Assets | -60,138.94 | Primarily losses from disposal of the company's fixed assets during the reporting period | | Government Subsidies Included in Current Profit and Loss | 375,094.42 | Primarily government subsidies received by the company during the reporting period | | Fair Value Changes and Disposal Gains/Losses of Financial Assets/Liabilities | 11,231,210.47 | Primarily investment income from disposal of financial assets held for trading and fair value change gains from holding financial assets held for trading during the reporting period | | Other Non-operating Income and Expenses | -65,982.81 | Primarily outstanding payments from resigned employees cleared by the company during the reporting period | | Less: Income Tax Impact | 1,714,551.81 | - | | Total | 9,765,631.33 | -- | Analysis of Major Financial Statement Item Changes During the reporting period, the company's financial position changed significantly with decreased monetary funds and increased financial assets held for trading, while profit was impacted by reduced government subsidies and expanded credit impairment losses, and operating cash flow turned negative due to increased employee compensation and reduced collections - Major balance sheet changes resulted from the company using idle funds to purchase structured deposits, leading to a 33.95% decrease in monetary funds and a 30.89% increase in financial assets held for trading[5] - Major income statement changes include a 95.22% year-on-year decrease in other income due to reduced government subsidies, and a 120.21% year-on-year increase in credit impairment losses due to higher bad debt provisions for accounts receivable[6] - Net cash flow from operating activities was -25.89 million yuan, a 130.03% year-on-year decrease, primarily due to increased cash paid to employees, reduced collections, and decreased government subsidies[9] Shareholder Information At the end of the reporting period, the company had 9,185 common shareholders, with the top three being domestic non-state-owned legal entities collectively holding over 30% of shares and having related party relationships, while some executives and core employees hold restricted shares related to incentive plans Common Shareholder Holdings As of the end of the reporting period, the total number of shareholders was 9,185, with Shihezi Xitai Equity Investment Partnership (Limited Partnership) as the largest shareholder at 18.58%, and actual controller Lai Chunbao directly and indirectly controlling a significant portion of shares with concerted action or related party relationships with other major shareholders Common Shareholder Holdings | Shareholder Name | Shareholder Nature | Shareholding Percentage | Number of Shares Held | | :--- | :--- | :--- | :--- | | Shihezi Xitai Equity Investment Partnership (Limited Partnership) | Domestic Non-state-owned Legal Entity | 18.58% | 14,773,473.00 | | Shihezi Ruixin Equity Investment Partnership (Limited Partnership) | Domestic Non-state-owned Legal Entity | 8.05% | 6,397,560.00 | | Shihezi Ruizesheng Equity Investment Co., Ltd. | Domestic Non-state-owned Legal Entity | 7.36% | 5,850,000.00 | | Shanghai Guanyou Investment Development Co., Ltd. - Guanyou Zhaotai... | Other | 6.88% | 5,474,040.00 | | Lai Chunbao | Domestic Natural Person | 5.85% | 4,648,150.00 | - Actual controller Lai Chunbao has control relationships with Shihezi Xitai and Shihezi Ruixin, two of the top three shareholders, and is a concerted action party with Shihezi Ruizesheng, additionally, he indirectly holds stakes in other institutional shareholders[11] Changes in Restricted Shares During the reporting period, the number of restricted shares held by major restricted shareholders increased due to capital reserve capitalization, while restricted shares of some executives and incentive recipients changed due to equity incentive plans, with total restricted shares at period-end being 32,374,252 shares Changes in Restricted Shares | Shareholder Name | Restricted Shares at Beginning of Period | Restricted Shares Increased This Period | Restricted Shares at End of Period | Reason for Restriction | | :--- | :--- | :--- | :--- | :--- | | Shihezi Xitai Equity Investment Partnership | 11,364,210 | 3,409,263 | 14,773,473 | Restricted Shares Before IPO | | Shihezi Ruixin Equity Investment Partnership | 4,921,200 | 1,476,360 | 6,397,560 | Restricted Shares Before IPO | | Shihezi Ruizesheng Equity Investment Co., Ltd. | 4,500,000 | 1,350,000 | 5,850,000 | Restricted Shares Before IPO | | Lai Chunbao | 3,415,500 | 1,024,650 | 4,440,150 | Restricted Shares Before IPO | | Total | 24,971,060 | 7,522,467 | 32,374,252 | -- | Other Significant Matters Facing challenges from changes in the biopharmaceutical industry's investment and financing environment, the company actively responded by reserving business personnel to expand service capabilities, leading to short-term profit pressure, while also implementing its 2024 semi-annual equity distribution plan - In the first three quarters of 2024, the company's net profit decline was primarily due to increased operating costs from reserving business personnel based on business needs[14] - As of the end of the reporting period, the company's total employees reached 4,692, with nearly 4,500 professional business personnel, having cumulatively served over 940 clinical trial institutions and executing 2,011 SMO projects[14] - The company implemented its 2024 semi-annual profit distribution, distributing a cash dividend of 1.50 yuan (tax inclusive) per 10 shares based on 79,508,000 shares, totaling 11.93 million yuan[15] Quarterly Financial Statements This section provides the unaudited consolidated balance sheet, consolidated income statement, and consolidated cash flow statement for the third quarter of 2024, revealing a slight increase in total assets, a decrease in liabilities, an increase in owners' equity, revenue growth without corresponding profit growth, and a deterioration in operating cash flow Consolidated Balance Sheet As of the end of the reporting period, the company's total assets were 1.38 billion yuan, a 1.01% increase from the beginning of the period, with current assets constituting the majority, while total liabilities decreased by 16.20% to 240 million yuan, and owners' equity attributable to shareholders increased by 5.57% to 1.14 billion yuan Consolidated Balance Sheet | Item | Balance at End of Period (Yuan) | Balance at Beginning of Period (Yuan) | | :--- | :--- | :--- | | Total Assets | 1,380,627,358.88 | 1,366,819,029.33 | | Monetary Funds | 325,825,066.73 | 493,333,898.29 | | Financial Assets Held for Trading | 551,222,611.90 | 421,141,557.44 | | Accounts Receivable | 137,268,714.34 | 124,209,050.46 | | Contract Assets | 323,326,787.12 | 283,809,093.50 | | Total Liabilities | 239,858,291.83 | 286,223,762.86 | | Total Owners' Equity | 1,140,769,067.05 | 1,080,595,266.47 | Consolidated Income Statement In the first three quarters of 2024, the company achieved total operating revenue of 594 million yuan, a 9.17% year-on-year increase, but total operating costs increased by 18.10% to 515 million yuan, leading to a 30.00% year-on-year decrease in operating profit and a 28.39% year-on-year decrease in net profit attributable to shareholders Consolidated Income Statement | Item | Amount for Current Period (Yuan) | Amount for Prior Period (Yuan) | | :--- | :--- | :--- | | I. Total Operating Revenue | 593,655,432.66 | 543,812,468.80 | | II. Total Operating Costs | 515,066,734.91 | 436,146,127.89 | | Including: Operating Costs | 448,072,661.19 | 379,074,325.70 | | III. Operating Profit | 83,618,732.92 | 119,352,708.25 | | V. Net Profit | 72,264,346.75 | 100,909,810.49 | | Net Profit Attributable to Parent Company Shareholders | 72,264,346.75 | 100,909,810.49 | | VIII. Earnings Per Share (Basic) | 1.09 | 1.68 | Consolidated Cash Flow Statement In the first three quarters of 2024, net cash flow from operating activities was -25.89 million yuan, a significant 130.03% year-on-year decrease, while net cash outflow from investing activities was 126 million yuan, and net cash outflow from financing activities was 16.02 million yuan, with cash and cash equivalents at period-end totaling 326 million yuan Consolidated Cash Flow Statement | Item | Amount for Current Period (Yuan) | Amount for Prior Period (Yuan) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | -25,890,406.88 | 86,205,851.78 | | Net Cash Flow from Investing Activities | -125,600,999.95 | -392,954,007.36 | | Net Cash Flow from Financing Activities | -16,017,424.73 | -5,646,701.78 | | V. Net Increase in Cash and Cash Equivalents | -167,508,831.56 | -312,394,857.36 | | VI. Cash and Cash Equivalents at End of Period | 325,825,066.73 | 365,050,387.60 |